The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment.
Neurotrophic factors are critical regulators of the formation and plasticity of neuronal networks. Brain-derived neurotrophic factor (BDNF) is abundant in the brain and periphery, and is found in both human serum and plasma. Animal studies have demonstrated that stress reduces BDNF expression or activity in the hippocampus and that this reduction can be prevented by treatment with antidepressant drugs. A similar change in BDNF activity occurs in the brain of patients with major depression disorder (MDD). Recently, clinical studies have indicated that serum or plasma BDNF levels are decreased in untreated MDD patients. Antidepressant treatment for at least four weeks can restore the decreased BDNF function up to the normal value. Therefore, MDD is associated with impaired neuronal plasticity. Suicidal behavior can be a consequence of severe impaired neuronal plasticity in the brain. Antidepressant treatment promotes increased BDNF activity as well as several forms of neuronal plasticity, including neurogenesis, synaptogenesis and neuronal maturation. BDNF could also play an important role in the modulation of neuronal networks. Such a neuronal plastic change can positively influence mood or recover depressed mood. These alterations of BDNF levels or neuronal plasticity in MDD patients before and after antidepressant treatment can be measured through the examination of serum or plasma BDNF concentrations. BDNF levels can therefore be useful markers for clinical response or improvement of depressive symptoms, but they are not diagnostic markers of major depression.
Department of Psychiatry, College of Medicine, Korea University, Seoul, Korea.
Bun-Hee
BH
Lee
Yong-Ku
YK
Kim
Eur J Neurosci. 2005 Mar;21(5):1299-303
15813939
Curr Opin Pharmacol. 2007 Feb;7(1):18-21
17049922
Neuroscience. 2007 Jan 5;144(1):368-74
17049169
Arch Gen Psychiatry. 2003 Aug;60(8):804-15
12912764
Brain Res Mol Brain Res. 1996 Mar;36(2):280-6
8965648
Neuropharmacology. 2003 Jun;44(7):903-10
12726822
J Neurosci. 2004 Mar 17;24(11):2667-77
15028759
J Affect Disord. 2008 Jan;105(1-3):279-83
17553570
Neuropsychopharmacology. 2002 Aug;27(2):133-42
12093587
Biol Psychiatry. 2005 May 1;57(9):1068-72
15860348
J Neurosci. 2003 Jan 1;23(1):349-57
12514234
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):78-85
16904252
Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):381-6
15809771
Biol Psychiatry. 2003 Nov 15;54(10):972-82
14625139
Thromb Haemost. 2002 Apr;87(4):728-34
12008958
Neuropsychobiology. 2008;57(4):194-9
18679038
Trends Pharmacol Sci. 2003 Mar;24(3):116-21
12628355
Biol Psychiatry. 2001 Aug 15;50(4):260-5
11522260
Behav Brain Res. 2001 Apr 8;120(1):87-95
11173088
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1034-7
17459550
Neurosci Res. 1997 Jun;28(2):103-10
9220467
J Psychiatr Res. 2009 Jan;43(3):247-54
18511076
Biol Psychiatry. 2003 Jul 1;54(1):70-5
12842310
Neuropsychopharmacology. 2000 Aug;23(2):205-15
10882847
Hippocampus. 2006;16(3):239-49
16425236
J Neurosci. 1995 Mar;15(3 Pt 1):1768-77
7891134
Cell Mol Life Sci. 2001 Jul;58(8):1045-53
11529497
Biol Psychiatry. 2006 Jun 15;59(12):1116-27
16631126
Lancet. 1998 Nov 28;352(9142):1754-5
9848357
Nat Rev Neurosci. 2005 Aug;6(8):603-14
16062169
Psychiatry Res. 2002 Mar 15;109(2):143-8
11927139
Brain Res. 1998 Nov 30;813(1):112-20
9824681
Behav Neurosci. 2001 Oct;115(5):1145-53
11584927
Neuropharmacology. 1998 Dec;37(12):1553-61
9886678
Neuropsychobiology. 2007;56(2-3):93-7
18037819
Int J Neuropsychopharmacol. 2008 Dec;11(8):1047-61
18611289
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10827-32
15249684
Int J Neuropsychopharmacol. 2008 Dec;11(8):1169-80
18752720
Brain Res. 2008 May 23;1211:37-43
18433734
Biol Psychiatry. 2003 Oct 1;54(7):703-9
14512210
Brain Res. 2004 Mar 12;1000(1-2):148-55
15053962
Mol Psychiatry. 2002;7(6):609-16
12140784
Arch Gen Psychiatry. 2009 Jan;66(1):22-32
19124685
Eur Psychiatry. 2002 Jul;17 Suppl 3:306-10
15177086
Nat Neurosci. 2006 Apr;9(4):519-25
16501568
Brain Res. 2004 Oct 29;1025(1-2):10-20
15464739
Biol Psychiatry. 2009 Feb 15;65(4):319-28
18930453
Endocrinology. 1998 Jul;139(7):3112-8
9645683
Mol Psychiatry. 2007 Nov;12(11):981-3
17957235
Neuroscience. 2004;128(3):597-604
15381288
Neuroscience. 2006;139(3):1017-29
16500030
Crit Rev Neurobiol. 2004;16(1-2):43-9
15581398
J Affect Disord. 2007 Aug;101(1-3):239-44
17173978